Antigen
Something the immune system recognizes. A piece of a virus, a tumor marker, a foreign protein.
Reference
Medical Animation Glossary
Plain-English definitions of the biology, drug modalities, and production craft that come up most often in our briefs. Written for small and mid-size biotech, pharma, and medical product teams who need shared vocabulary before a kickoff call without wading through textbook density.
Cell Biology
- Antigens are the labels the immune system reads. Every antibody and every T-cell is built to recognize one specific antigen. Tumor antigens are especially important in cancer immunotherapy because they tell the immune system, 'this is the right target.' In animation, antigens often appear as small flags or shapes on a cell surface.
Apoptosis
Programmed cell death. The body's tidy way of removing damaged or unwanted cells.
- Apoptosis is the cell's quiet self-shutdown. The cell breaks itself into small packages that the body cleans up without inflammation. Many cancer therapies aim to push tumor cells into this state. In animation, the cell's gradual collapse is one of the more emotional beats and benefits from soft pacing.
Binding Affinity
How tightly a drug holds onto its target. Tighter usually means more potent.
- Binding affinity is a measure of stickiness. A drug with higher affinity stays attached to its target longer and at lower concentrations, which usually means a smaller dose can do the job. In animation, affinity is rarely shown as a number; instead it shows up in pacing and how the molecule settles into place.
Immune Checkpoint
Built-in brakes on the immune system. Cancer can hijack them to avoid attack.
- Checkpoints normally stop the immune system from attacking healthy tissue. Some tumors press these brakes deliberately, which lets them grow unchecked. Checkpoint inhibitor drugs release the brake so immune cells can do their job. The brake-release moment is usually the visual climax of a checkpoint MOA piece.
Receptor
A protein that sits on or inside a cell and listens for a specific signal.
- Receptors are how cells take in information. When the right molecule docks, the receptor changes shape and sets off an internal response. Drugs are often designed to either turn a receptor on, block it, or fine-tune it. In animation, receptors are usually drawn as shaped pockets on the cell surface, ready to receive their match.
Receptor Binding
The moment a drug or signaling molecule attaches to its target receptor.
- Receptor binding is the starting whistle for most drug effects. The drug fits into a pocket on the receptor like a key in a lock, the receptor responds, and the chain of events inside the cell begins. Binding scenes are the most-watched moment in many MOA pieces because they make the abstract idea of a drug feel physical.
T-cell
An immune cell that recognizes specific threats and orchestrates the response.
- T-cells are the targeted enforcers of the immune system. Some kill infected or tumor cells directly. Others coordinate the broader immune response. Many modern cancer therapies are designed to support or redirect T-cells. In animation, T-cells are usually drawn as confident, mobile actors that move with intent.
Tumor Microenvironment
The neighborhood around a tumor. Other cells, blood vessels, and signals that help it survive.
- Tumors are not isolated lumps of cancer cells. They sit inside a complex local ecosystem that helps them hide from the immune system and resist treatment. Modern oncology stories increasingly show this neighborhood instead of just the tumor itself, which is a richer animation brief and tends to land better with informed audiences.
Clinical
Clinical Trial Phases
The sequential studies a drug goes through before approval. Phase 1, 2, and 3.
- Phase 1 trials test safety in a small group. Phase 2 trials test whether the drug actually does something useful in patients. Phase 3 trials test it at scale to confirm it works and is safe enough for broad approval. After approval, post-market studies keep watching. Animations explaining trial design are increasingly used in patient recruitment and investor updates because the structure can feel opaque without visual help.
Dose-Response
The relationship between how much drug is given and how much effect you see.
- Dose-response is the curve that says, 'at this dose you get this much effect.' Researchers use it to find the sweet spot between too little (no effect) and too much (side effects). In team training pieces, dose-response curves often appear as a quick chart-and-cell visual that anchors the conversation about dosing.
Half-life
How long it takes for half of a drug to clear from the body.
- Half-life shapes the dosing schedule. Short half-life drugs may need infusions or daily doses. Long half-life biologics can be given once a month or once a quarter, which is often a real selling point for patients. In animation, half-life is rarely the headline but often shows up as a quiet timeline element.
Pharmacodynamics (PD)
What a drug does to the body. The visible effect at the cell or tissue level.
- PD is the other side of PK. Where PK tracks where the drug goes, PD tracks what happens once it gets there. In a medical animation, PD is the part of the story where the molecule binds, the cell responds, and the effect plays out. PD scenes are common in team training pieces because they make the science feel concrete.
Pharmacokinetics (PK)
What the body does to a drug. Where it goes, how long it stays, how it leaves.
- PK answers the practical questions investors and physicians ask: how is the drug absorbed, where does it travel, how long does it last, and how is it cleared. In animation, PK shows up as a journey: the dose enters, the drug spreads into tissues, the body breaks it down, and the rest leaves. PK animations are common when the dose form (oral, injectable, infusion) is part of the story.
Regulatory Submission
The official package a sponsor files with regulators to ask for approval.
- A regulatory submission is the moment when a sponsor formally hands over its data and asks for permission to dose patients or sell the therapy. Regulators read through it, ask questions, and decide. MOA animations are increasingly included as supplementary materials in these packages and in the meetings that surround them, because reviewers benefit from a clear visual of the drug's action.
Discovery
Knockout
A controlled experiment where a target gene is fully switched off to see what it does.
- Researchers use knockouts to learn what a gene is for. By removing it from a cell or animal, they can study how the system behaves without it, which is often the cleanest way to validate a new drug target. Modern editing tools have made knockouts routine. In animation, knockout scenes are most useful when the brief is about target validation rather than therapy.
Mechanism
Mechanism of Action (MOA)
How a drug or therapy actually works inside the body, told as a short visual story.
- An MOA is the simple answer to the question, 'what does your drug do, and where does it do it?' In medical animation, an MOA piece walks the viewer through that story: the drug reaches its target, attaches to it, and triggers an effect that helps the patient. MOA videos are the most common ask for investor decks, conference booths, sales team training, and patient-facing content. A standard MOA animation runs 30 to 60 seconds and focuses on a single target. Multi-mechanism films run longer and are scoped at the discovery call.
Modality
Adeno-Associated Virus (AAV)
A safe, well-studied virus used as a delivery vehicle for gene therapies.
- AAV is a small, harmless virus that researchers have repurposed as a delivery van. The viral genes are removed, the therapeutic gene is loaded in, and the AAV carries that cargo to specific tissues like the eye, liver, muscle, or central nervous system. In animation, AAV scenes are recognizable by the small icosahedral particle docking onto a cell.
Antibody
A Y-shaped protein the immune system uses to find and tag a specific target.
- Antibodies are the body's targeting system. The two arms of the Y stick to a chosen target (a virus, a tumor cell, a misfolded protein) and the stem signals the rest of the immune system or carries an attached drug. Therapeutic antibodies come in several formats and underpin a large share of modern biotech pipelines. In animation, antibody binding is a clean, recognizable beat that anchors the viewer.
Antibody-Drug Conjugate (ADC)
An antibody carrying a small drug payload, like a guided package.
- An ADC has three parts: an antibody that finds the target, a small drug attached to it, and a connector designed to release the drug at the right moment. The antibody acts as the address label, and the drug is delivered inside the cell rather than scattered through the body. In animation, the release moment inside the target cell is usually the visual climax.
Antisense Oligonucleotide (ASO)
A short piece of synthetic DNA or RNA that controls how a target message is read.
- ASOs work alongside the cell's own machinery. They stick to a specific message inside the cell and either cause it to be destroyed, change how it gets read, or prevent it from being translated into protein. ASOs are most often used in rare disease where switching off a single faulty message can change the outcome.
Bispecific Antibody
An antibody engineered to grab two different targets at once.
- A bispecific antibody has two grippers instead of one. The most common use is to hold a tumor cell with one arm and an immune cell with the other, pulling them together so the immune cell can do its job. In animation, the bridge moment between two cells is the signature beat that makes a bispecific story click.
CAR-T Cell Therapy
A patient's own immune cells are taken out, taught to recognize cancer, and put back.
- CAR-T is a personalized therapy. Doctors collect immune cells from the patient, add a custom receptor in the lab so the cells can recognize a tumor, grow them into large numbers, and infuse them back. Once inside, the engineered cells search for and destroy the cancer. In animation, CAR-T pieces almost always include the lab journey because it is what makes the therapy feel real.
CRISPR / Cas9
A way to edit DNA at a specific spot. A guide molecule shows the editor where to cut.
- CRISPR is a precise gene-editing tool. A short guide molecule pairs with the matching DNA sequence in the cell, and a partner protein (Cas9) makes a clean cut at that exact spot. The cell then either disables the gene or, with help, swaps in a corrected version. In animation, CRISPR is one of the most rewarding stories to tell because the action is dramatic and the visual logic is clear.
Endosomal Escape
How a delivery vehicle releases its cargo before the cell breaks it down.
- When a delivery particle enters a cell, it lands in a small bubble that gradually becomes more acidic and is meant to digest its contents. To do its job, the cargo has to escape that bubble before that happens. Modern delivery vehicles like LNPs are designed to break out at the right moment. In animation, this is one of the most satisfying beats: the cargo bursts free into the cell's interior.
Gene Therapy
Adding, fixing, or switching off a gene to treat a disease at its root.
- Gene therapy works at the source. A delivery vehicle carries genetic material into the right cells, where it either replaces a missing function, silences a harmful one, or corrects a faulty letter in the DNA. The therapy can be done inside the body or in the lab using cells taken from the patient. In animation, the delivery, integration, and effect are usually three distinct beats that benefit from clear pacing.
Lipid Nanoparticle (LNP)
A tiny fatty bubble that protects a delicate cargo and helps it get inside cells.
- LNPs are the delivery vehicle for many modern therapies. They wrap mRNA or other nucleic acid cargo in a small fatty shell, slip past the cell membrane, and release the cargo where it can act. In animation, the LNP scene is usually the bridge between the dose and the cellular effect, and it is one of the most distinctive visual moments in any mRNA piece.
Monoclonal Antibody (mAb)
An antibody made from a single source so every copy is identical and predictable.
- Monoclonal antibodies are produced from one cell line, which means every molecule looks and acts the same way. That uniformity is what makes them safe and effective drugs. Names ending in -mab are the giveaway. In animation, mAbs are the workhorse target-binding scene: same Y-shape, same target, same effect every time.
mRNA Therapy
A short message delivered into cells that tells them to make a specific protein.
- mRNA therapies use the cell's own protein-making machinery. A small lipid bubble carries the message inside the cell, the cell reads it, and produces the target protein. The same approach powered the first widely used mRNA vaccines and is now being tested in cancer, rare disease, and protein-replacement programs. Animation works well here because it lets viewers see the message arrive, get translated, and disappear.
siRNA / RNA Interference
A way to switch off a specific gene by destroying the message that copies it.
- siRNA therapies use short pieces of RNA that find a matching message inside the cell and tag it for destruction. The result is fewer copies of the protein the body should not be making. Several siRNA therapies are now used regularly in liver-targeted disease. In animation, the moment when the message is found and silenced is the natural visual peak.
Production
Render
The compute step that turns 3D scene data into the final video frames.
- Rendering is what produces the polished video at the end. The 3D scene is set up, the cameras and lights are placed, and the computer calculates each frame one by one. High-fidelity scientific scenes (translucent biology, molecular detail) take longer to render because every pixel carries a lot of light interaction. Render time is one of the larger cost levers on a 3D piece.
Storyboard
A frame-by-frame plan of the animation. The narrative is locked here, before production starts.
- A storyboard is the working script in visual form. Each panel captures the key moment of a beat: what is on screen, what the camera is doing, what the voiceover is saying. Sign-off on the storyboard is the moment when the team agrees on the story. After that, changing the narrative is expensive, so storyboards are where collaboration happens most.
Style Frames
Polished still images that lock the visual look of the animation before motion starts.
- Style frames are like a movie poster for each scene. They show color, lighting, level of detail, and on-screen text in their final form. The team approves the look here so that motion design moves forward with no surprises. A few style frames cover the main scene types in the piece.
Voiceover
The recorded narration that carries the spoken script across the animation.
- The voiceover is recorded once the script is locked. The animation is then timed to match it, so pacing, emphasis, and breath shape what the viewer feels. Professional voice sessions deliver a few different reads so the team can pick what fits best. Total runtime is driven by the voiceover length, which is why the script is locked early.
Need a term we missed?
Our team writes new entries every quarter. Tell us what is ambiguous in your brief and we will add a definition with a visual example.